Ausgabe 3/2021
Inhalt (11 Artikel)
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges
Sukhmani Pannu, David Rosmarin
Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma
Dimitrios C. Ziogas, Frosso Konstantinou, Spyros Bouros, Maria Theochari, Helen Gogas
50 Years of Topical Retinoids for Acne: Evolution of Treatment
Hilary Baldwin, Guy Webster, Linda Stein Gold, Valerie Callender, Fran E. Cook-Bolden, Eric Guenin
Dermatitis Herpetiformis: An Update on Diagnosis and Management
Timo Reunala, Kaisa Hervonen, Teea Salmi
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm
Daniela Michelle Pérez-Garza, Sonia Chavez-Alvarez, Jorge Ocampo-Candiani, Minerva Gomez-Flores
Management of Difficult-to-Treat Warts: Traditional and New Approaches
Peter C. Friedman
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
Brett King, Catherine Maari, Edward Lain, Jonathan I. Silverberg, Maher Issa, Katrin Holzwarth, Dennis Brinker, Tracy Cardillo, Fabio P. Nunes, Eric L. Simpson
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
Ellen J. Kim, Joan Guitart, Christiane Querfeld, Michael Girardi, Amy Musiek, Oleg E. Akilov, James T. Angello, William L. Bailey, Larisa J. Geskin
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial
Soufila KT, Vishal Thakur, Tarun Narang, Sunil Dogra, Sanjeev Handa